MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Penumbra P/CF Ratio 2011-2026 | PEN
Annual P/CF Ratio Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.3 | 61.9 | 104 | -178 | 858 | -306 | 1.36 K | 254 | -1.43 K | -81.7 | -18.5 | -1.32 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 K | -1.43 K | 56.9 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | USA |
 |
Insulet Corporation
PODD
|
31.9 | $ 216.0 | -4.21 % | $ 15.2 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | USA |
 |
Profound Medical Corp.
PROF
|
-10.3 | $ 5.82 | 13.01 % | $ 180 M |  Canada |
 |
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
-3.49 | $ 3.96 | 3.66 % | $ 169 M | USA |
 |
AVITA Medical
RCEL
|
-3.32 | $ 3.99 | 3.91 % | $ 111 M |  Australia |
 |
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-7.13 | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | USA |
 |
IRadimed Corporation
IRMD
|
50.2 | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
-0.806 | $ 2.56 | -0.39 % | $ 7.1 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
7.72 | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
33.9 | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | USA |
 |
Sensus Healthcare
SRTS
|
137 | $ 4.22 | 6.57 % | $ 68.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-0.366 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
15.3 | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-25 | - | - | $ 111 M | Canada |
 |
Tactile Systems Technology
TCMD
|
14.9 | $ 26.96 | 0.37 % | $ 617 M | USA |
 |
TELA Bio
TELA
|
-3.21 | $ 0.69 | -9.35 % | $ 15.8 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-130 | $ 24.26 | -1.02 % | $ 1.65 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-3.77 | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
-0.396 | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
-3.28 | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
2 | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Myomo
MYO
|
-2.34 | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-7.05 | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-90 | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Outset Medical
OM
|
-0.00113 | $ 3.53 | - | $ 53.7 K | USA |
 |
Inspire Medical Systems
INSP
|
15.1 | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Varex Imaging Corporation
VREX
|
12 | $ 10.69 | 0.66 % | $ 443 M | USA |